The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats

Neurogastroenterology and Motility

Volumn 20, Issue 9, 2008, Pages 1030-1041

  Vasina, V ^b   Abu Gharbieh, E ^c   Barbara, G ^b   De Giorgio, R ^b   Colucci, R ^d   Blandizzi, C ^d   Bernardini, N ^d   Croci, T ^e   Del Tacca, M ^d   De Ponti, F ^a,b  

^a Department of Pharmacology ^*  (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF JORDAN   (Jordan)

^d UNIVERSITY OF PISA   (Italy)

^e Sanofi Midy Research Centre   (Italy)

Author keywords

Adrenoceptors; Colitis; Enteric neurons

Indexed keywords

[[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; BETA 3 ADRENERGIC RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; 1 FLUORO 2,4 DINITROBENZENE; 2,4 DINITROFLUOROBENZENE SULFONIC ACID; 2,4-DINITROFLUOROBENZENE SULFONIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; DRUG DERIVATIVE; STEM CELL FACTOR RECEPTOR; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOREACTIVITY; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COLON; CYTOLOGY; DOSE RESPONSE; DRUG POTENTIATION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; BODY WEIGHT; COLITIS; COLON; CYTOKINES; DINITROFLUOROBENZENE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; MALE; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-3; TETRAHYDRONAPHTHALENES;

EID: 49749120050     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01138.x     Document Type: Article

References (42)

1. De Ponti F, Gibelli G, Croci T, Arcidiaco M, Crema F, Manara L. Functional evidence of atypical beta 3-adrenoceptors in the human colon using the beta 3-selective adrenoceptor antagonist, SR 59230A. Br J Pharmacol 1996 117 : 1374 6.
2. Bianchetti A, Manara L. In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon. Br J Pharmacol 1990 100 : 831 9.
3. Kelly J, Houston G. Beta 3-adrenoceptors mediating relaxation of the oesophageal tunica muscularis mucosae and distal colon in the rat: comparative pharmacology and their desensitization by BRL 37344. J Auton Pharmacol 1996 16 : 205 11.
4. De Ponti F, Modini C, Gibelli G, Crema F, Frigo G. Atypical beta-adrenoceptors mediating relaxation in the human colon: functional evidence for beta3-rather than beta4-adrenoceptors. Pharmacol Res 1999 39 : 345 8.
5. Anthony A, Schepelmann S, Guillaume JL et al. Localization of the beta(beta)3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 1998 12 : 519 25.
6. Cellek S, Thangiah R, Bassil AK et al. Demonstration of functional neuronal beta(3)-adrenoceptors within the enteric nervous system. Gastroenterology 2007 133 : 175 83.
7. Anthony A, Bahl AK, Oakley IG et al. The beta 3-adrenoceptor agonist CL316243 prevents indomethacin-induced jejunal ulceration in the rat by reversing early villous shortening. J Pathol 1996 179 : 340 6.
8. Coruzzi G, Bertaccini G. The beta3-adrenoceptor agonist SR58611A inhibits gastric acid secretion in the conscious cat. Naunyn Schmiedebergs Arch Pharmacol 1997 356 : 263 5.
9. Bertini S, Coruzzi G, Intorre L, Soldani G. Effects of beta3-adrenoceptor agonist SR 58611A on gastric acid secretion and histamine release in the dog: comparison with ritodrine. Gen Pharmacol 1998 31 : 625 31.
10. Kelly D, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. Reversal and protection against indomethacin-induced blood stasis and mucosal damage in the rat jejunum by a beta3-adrenoceptor agonist. Aliment Pharmacol Ther 1998 12 : 1121 9.
11. Vinay HK, Paul A, Goswami SS, Santani D. Effect of SR 58611A, a beta-3 receptor agonist, against experimental gastro-duodenal ulcers. Indian J Physiol Pharmacol 2002 46 : 36 44.
12. Zhao A, Bossone C, Pineiro-Carrero V, Shea-Donohue T. Colitis-induced alterations in adrenergic control of circular smooth muscle in vitro in rats. J Pharmacol Exp Ther 2001 299 : 768 74.
13. Blandizzi C, Fornai M, Colucci R et al. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 2003 139 : 309 20.
14. Manara L, Croci T, Landi M. Beta 3-adrenoceptors and intestinal motility. Fundam Clin Pharmacol 1995 9 : 332 42.
15. Giudice A, Croci T, Bianchetti A, Manara L. Inhibition of rat colonic motility and cardiovascular effects of new gut-specific beta-adrenergic phenylethanolaminotetralines. Life Sci 1989 44 : 1411 7.
16. Montastruc JL, Verwaerde P, Pelat M et al. Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect. Fundam Clin Pharmacol 1999 13 : 180 6.
17. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995 109 : 1344 67.
18. Wallace JL, Le T, Carter L, Appleyard CB, Beck PL. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharmacol Toxicol Methods 1995 33 : 237 9.
19. De Ponti F, Gibelli G, Crema F, Lecchini S. Functional evidence for the presence of beta 3-adrenoceptors in the guinea pig common bile duct and colon. Pharmacology 1995 51 : 288 97.
20. Sturiale S, Barbara G, Qiu B et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 1999 96 : 11653 8.
21. Boughton-Smith NK, Wallace JL, Whittle BJ. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 1988 25 : 115 23.
22. Jacobson K, McHugh K, Collins SM. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995 109 : 718 22.
23. Pluja L, Alberti E, Fernandez E, Mikkelsen HB, Thuneberg L, Jimenez M. Evidence supporting presence of two pacemakers in rat colon. Am J Physiol Gastrointest Liver Physiol 2001 281 : G255 66.
24. Faussone-Pellegrini MS, Gay J, Vannucchi MG, Corsani L, Fioramonti J. Alterations of neurokinin receptors and interstitial cells of Cajal during and after jejunal inflammation induced by Nippostrongylus brasiliensis in the rat. Neurogastroenterol Motil 2002 14 : 83 95.
25. Bernardini N, Colucci R, Mattii L et al. Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon. Neurogastroenterol Motil 2006 18 : 654 62.
26. Reber L, Da Silva CA, Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur J Pharmacol 2006 533 : 327 40.
27. Vanderwinden JM, Rumessen JJ, Bernex F, Schiffmann SN, Panthier JJ. Distribution and ultrastructure of interstitial cells of Cajal in the mouse colon, using antibodies to Kit and Kit(W-lacZ) mice. Cell Tissue Res 2000 302 : 155 70.
28. Kinoshita K, Horiguchi K, Fujisawa M et al. Possible involvement of muscularis resident macrophages in impairment of interstitial cells of Cajal and myenteric nerve systems in rat models of TNBS-induced colitis. Histochem Cell Biol 2007 127 : 41 53.
29. Ward SM, Beckett EA, Wang X, Baker F, Khoyi M, Sanders KM. Interstitial cells of Cajal mediate cholinergic neurotransmission from enteric motor neurons. J Neurosci 2000 20 : 1393 403.
30. Wang XY, Sanders KM, Ward SM. Relationship between interstitial cells of Cajal and enteric motor neurons in the murine proximal colon. Cell Tissue Res 2000 302 : 331 42.
31. Ward SM, Sanders KM, Hirst GD. Role of interstitial cells of Cajal in neural control of gastrointestinal smooth muscles. Neurogastroenterol Motil 2004 16 (Suppl. 1 112 7.
32. Dong LW, Yang J, Tong LJ, Tang C, Liu MS. Transcriptional regulation of alpha-1adrenoceptor gene in the rat liver during different phases of sepsis. Biochim Biophys Acta 1999 1453 : 207 15.
33. Wang XY, Berezin I, Mikkelsen HB et al. Pathology of interstitial cells of Cajal in relation to inflammation revealed by ultrastructure but not immunohistochemistry. Am J Pathol 2002 160 : 1529 40.
34. Wang XY, Vannucchi MG, Nieuwmeyer F, Ye J, Faussone-Pellegrini MS, Huizinga JD. Changes in interstitial cells of Cajal at the deep muscular plexus are associated with loss of distention-induced burst-type muscle activity in mice infected by Trichinella spiralis. Am J Pathol 2005 167 : 437 53.
35. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996 111 : 1683 99.
36. Hurst SM, Stanisz AM, Sharkey KA, Collins SM. Interleukin 1 beta-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993 105 : 1754 60.
37. Abrass CK, O'Connor SW, Scarpace PJ, Abrass IB. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 1985 135 : 1338 41.
38. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990 145 : 1430 4.
39. Izeboud CA, Monshouwer M, van Miert AS, Witkamp RF. The beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflamm Res 1999 48 : 497 502.
40. Severn A, Rapson NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 1992 148 : 3441 5.
41. Sevak R, Paul A, Goswami S, Santani D. Gastroprotective effect of beta3 adrenoreceptor agonists ZD 7114 and CGP 12177A in rats. Pharmacol Res 2002 46 : 351 6.
42. Kuratani K, Kodama H, Yamaguchi I. Enhancement of gastric mucosal blood flow by beta-3 adrenergic agonists prevents indomethacin-induced antral ulcer in the rat. J Pharmacol Exp Ther 1994 270 : 559 65.